Global Afamelanotide Market Set to Reach USD 258.01 Million by 2032 Amid Rising Demand for Rare Disease Therapies
  According to a new report from Intel Market Research, the global Afamelanotide market was valued at USD 136.27 million in 2024 and is projected to reach USD 258.01 million by 2032, growing at a robust CAGR of 9.1% during the forecast period (2025–2032). This growth is propelled by the increasing global prevalence of rare phototoxic disorders, heightened awareness about orphan...
0 Reacties 0 aandelen 8 Views 0 voorbeeld